17-78425386-A-G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_173628.4(DNAH17):​c.13101T>C​(p.Pro4367Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.164 in 1,613,646 control chromosomes in the GnomAD database, including 23,050 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2446 hom., cov: 32)
Exomes 𝑓: 0.16 ( 20604 hom. )

Consequence

DNAH17
NM_173628.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -2.23

Publications

15 publications found
Variant links:
Genes affected
DNAH17 (HGNC:2946): (dynein axonemal heavy chain 17) Dyneins are microtubule-associated motor protein complexes composed of several heavy, light, and intermediate chains. DNAH17 is a heavy chain associated with axonemal dynein (Milisav and Affara, 1998 [PubMed 9545504]).[supplied by OMIM, Mar 2008]
DNAH17 Gene-Disease associations (from GenCC):
  • spermatogenic failure 39
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 17-78425386-A-G is Benign according to our data. Variant chr17-78425386-A-G is described in ClinVar as Benign. ClinVar VariationId is 402671.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-2.23 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.226 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH17NM_173628.4 linkc.13101T>C p.Pro4367Pro synonymous_variant Exon 80 of 81 ENST00000389840.7 NP_775899.3 Q9UFH2-1
DNAH17XM_011525416.3 linkc.13113T>C p.Pro4371Pro synonymous_variant Exon 80 of 81 XP_011523718.1
DNAH17XM_024451013.2 linkc.12969T>C p.Pro4323Pro synonymous_variant Exon 79 of 80 XP_024306781.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH17ENST00000389840.7 linkc.13101T>C p.Pro4367Pro synonymous_variant Exon 80 of 81 5 NM_173628.4 ENSP00000374490.6 Q9UFH2-1

Frequencies

GnomAD3 genomes
AF:
0.173
AC:
26294
AN:
151970
Hom.:
2443
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.230
Gnomad AMI
AF:
0.167
Gnomad AMR
AF:
0.130
Gnomad ASJ
AF:
0.231
Gnomad EAS
AF:
0.0306
Gnomad SAS
AF:
0.153
Gnomad FIN
AF:
0.111
Gnomad MID
AF:
0.206
Gnomad NFE
AF:
0.167
Gnomad OTH
AF:
0.179
GnomAD2 exomes
AF:
0.150
AC:
37697
AN:
251048
AF XY:
0.154
show subpopulations
Gnomad AFR exome
AF:
0.234
Gnomad AMR exome
AF:
0.0906
Gnomad ASJ exome
AF:
0.227
Gnomad EAS exome
AF:
0.0353
Gnomad FIN exome
AF:
0.114
Gnomad NFE exome
AF:
0.171
Gnomad OTH exome
AF:
0.166
GnomAD4 exome
AF:
0.163
AC:
238709
AN:
1461558
Hom.:
20604
Cov.:
33
AF XY:
0.163
AC XY:
118617
AN XY:
727064
show subpopulations
African (AFR)
AF:
0.235
AC:
7863
AN:
33478
American (AMR)
AF:
0.0931
AC:
4164
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.233
AC:
6080
AN:
26132
East Asian (EAS)
AF:
0.0217
AC:
860
AN:
39700
South Asian (SAS)
AF:
0.164
AC:
14108
AN:
86250
European-Finnish (FIN)
AF:
0.113
AC:
6057
AN:
53384
Middle Eastern (MID)
AF:
0.204
AC:
1178
AN:
5768
European-Non Finnish (NFE)
AF:
0.170
AC:
188583
AN:
1111752
Other (OTH)
AF:
0.163
AC:
9816
AN:
60370
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
10304
20609
30913
41218
51522
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
6656
13312
19968
26624
33280
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.173
AC:
26314
AN:
152088
Hom.:
2446
Cov.:
32
AF XY:
0.168
AC XY:
12521
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.230
AC:
9520
AN:
41436
American (AMR)
AF:
0.130
AC:
1986
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.231
AC:
801
AN:
3468
East Asian (EAS)
AF:
0.0305
AC:
158
AN:
5182
South Asian (SAS)
AF:
0.153
AC:
736
AN:
4820
European-Finnish (FIN)
AF:
0.111
AC:
1181
AN:
10604
Middle Eastern (MID)
AF:
0.207
AC:
61
AN:
294
European-Non Finnish (NFE)
AF:
0.167
AC:
11344
AN:
67978
Other (OTH)
AF:
0.177
AC:
375
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
1093
2186
3279
4372
5465
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
274
548
822
1096
1370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.178
Hom.:
1638
Bravo
AF:
0.178
Asia WGS
AF:
0.0790
AC:
274
AN:
3478
EpiCase
AF:
0.168
EpiControl
AF:
0.176

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
May 04, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
Mar 29, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

DNAH17-related disorder Benign:1
Nov 18, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.55
DANN
Benign
0.54
PhyloP100
-2.2
Mutation Taster
=86/14
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs36119275; hg19: chr17-76421467; COSMIC: COSV53147123; COSMIC: COSV53147123; API